Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Caravaca-Fontan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Kidney International|September 24, 2019
Complement inhibitors are useful in secondary hemolytic uremic syndromesFernando Caravaca-Fontan, Manuel Praga
Case Reports in Nephrology|November 10, 2015
An Unexpected Cause of Severe HypokalemiaFernando Caravaca-Fontan, Olga Martinez-Saez, Maria Delgado-Yague, et al.
Kidney360|December 8, 2025
Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GlomerulonephritisFernando Caravaca-Fontan, Sayna Norouzi, Mingyi Huang, et al.
Glomerular Diseases|May 8, 2025
Quo Vadis Standardization of Anti-Nephrin Antibody Detection?Safak Mirioglu, Annette Bruchfeld, Fernando Caravaca-Fontan, et al.
Nefrologia|June 1, 2020
Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal functionSaúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 3, 2026
Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertaintiesFernando Caravaca-Fontan, Annette Bruchfeld, Sarah M Moran, et al.
Clinical Kidney Journal|November 17, 2025
The 2025 KDIGO IgA nephropathy guideline update: an ERA Immunonephrology Working Group perspectiveEleni Stamellou, Annette Bruchfeld, Fernando Caravaca-Fontan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2025
Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)Y K Onno Teng, Eleni Frangou, Andreas Kronbichler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2026
Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERAAglaia Chalkia, Eleni Frangou, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 17, 2024
Antibody-mediated podocytopathies: a disease entity that implies immunotherapyAndreas Kronbichler, Cecilia Barnini, Anna Matyjek, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Kidney International|September 24, 2019
Complement inhibitors are useful in secondary hemolytic uremic syndromesFernando Caravaca-Fontan, Manuel Praga
Case Reports in Nephrology|November 10, 2015
An Unexpected Cause of Severe HypokalemiaFernando Caravaca-Fontan, Olga Martinez-Saez, Maria Delgado-Yague, et al.
Kidney360|December 8, 2025
Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GlomerulonephritisFernando Caravaca-Fontan, Sayna Norouzi, Mingyi Huang, et al.
Glomerular Diseases|May 8, 2025
Quo Vadis Standardization of Anti-Nephrin Antibody Detection?Safak Mirioglu, Annette Bruchfeld, Fernando Caravaca-Fontan, et al.
Nefrologia|June 1, 2020
Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal functionSaúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 3, 2026
Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertaintiesFernando Caravaca-Fontan, Annette Bruchfeld, Sarah M Moran, et al.
Clinical Kidney Journal|November 17, 2025
The 2025 KDIGO IgA nephropathy guideline update: an ERA Immunonephrology Working Group perspectiveEleni Stamellou, Annette Bruchfeld, Fernando Caravaca-Fontan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2025
Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)Y K Onno Teng, Eleni Frangou, Andreas Kronbichler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2026
Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERAAglaia Chalkia, Eleni Frangou, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 17, 2024
Antibody-mediated podocytopathies: a disease entity that implies immunotherapyAndreas Kronbichler, Cecilia Barnini, Anna Matyjek, et al.
Pageof 2